Recent advances in the management of autoimmune pancreatitis in the era of artificial intelligence
暂无分享,去创建一个
[1] R. Braren,et al. Deep Convolutional Neural Network-Assisted Feature Extraction for Diagnostic Discrimination and Feature Visualization in Pancreatic Ductal Adenocarcinoma (PDAC) versus Autoimmune Pancreatitis (AIP) , 2020, Journal of clinical medicine.
[2] K. Koike,et al. Role of Endoscopic Ultrasonography-Guided Fine Needle Aspiration/Biopsy in the Diagnosis of Autoimmune Pancreatitis , 2020, Diagnostics.
[3] Myung-Hwan Kim,et al. Endoscopic ultrasound‐guided fine needle aspiration versus biopsy for diagnosis of autoimmune pancreatitis: Systematic review and comparative meta‐analysis , 2020, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.
[4] Patrick D. Powers,et al. Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis , 2020, Gut.
[5] K. Okazaki,et al. Japanese Clinical Diagnostic Criteria for Autoimmune Pancreatitis, 2018 , 2019, Pancreas.
[6] I. Tsuji,et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016 , 2019, Journal of Gastroenterology.
[7] P. Ruszniewski,et al. Risk factors and treatment of relapses in autoimmune pancreatitis: Rituximab is safe and effective , 2019, United European gastroenterology journal.
[8] V. Deshpande,et al. Autoimmune Pancreatitis Type 2 , 2019, The American journal of surgical pathology.
[9] G. Capurso,et al. Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta‐analysis , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[10] S. Leeds,et al. Does IgG4 level at the time of diagnosis correlate with disease outcome in IgG4-Related disease? , 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[11] Suresh T. Chari,et al. Autoimmune Pancreatitis , 2018, The American Journal of Gastroenterology.
[12] B. Petersen,et al. Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4‐related Disease , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[13] A. Amiot,et al. Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[14] M. Ebert,et al. Prevalence and Incidence of Autoimmune Pancreatitis in the Population Living in the Southwest of Germany , 2017, Digestion.
[15] K. Felix,et al. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma , 2017, Journal of Translational Medicine.
[16] S. Chari,et al. Azathioprine Maintenance Therapy to Prevent Relapses in Autoimmune Pancreatitis , 2017, Clinical and Translational Gastroenterology.
[17] S. Chari,et al. International consensus for the treatment of autoimmune pancreatitis. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[18] Suresh T. Chari,et al. Autoimmune Pancreatitis , 2017, Digestive Diseases and Sciences.
[19] T. Smyrk,et al. Lymphoplasmacytic sclerosing pancreatitis without IgG4 tissue infiltration or serum IgG4 elevation: IgG4-related disease without IgG4 , 2015, Modern Pathology.
[20] J. Stone,et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations , 2014, Annals of the rheumatic diseases.
[21] S. Chari,et al. Recent Advances in Autoimmune Pancreatitis. , 2009, Gastroenterology.
[22] L. Spahr,et al. Alcoholic pancreatitis: A tale of spirits and bacteria. , 2014, World journal of gastrointestinal pathophysiology.
[23] Wei-Chih Liao,et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis , 2012, Gut.
[24] T. Shimosegawa. The amendment of the Clinical Diagnostic Criteria in Japan (JPS2011) in response to the proposal of the International Consensus of Diagnostic Criteria (ICDC) for autoimmune pancreatitis. , 2012, Pancreas.
[25] D. Sahani,et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. , 2012, Arthritis and rheumatism.
[26] Michael J Levy,et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience , 2012, Gut.
[27] T. Itoi,et al. Use of samples from endoscopic ultrasound-guided 19-gauge fine-needle aspiration in diagnosis of autoimmune pancreatitis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[28] J. Stone,et al. Rituximab for the Treatment of IgG4-Related Disease: Lessons From 10 Consecutive Patients , 2012, Medicine.
[29] S. Giday,et al. Clinical Profile of Autoimmune Pancreatitis and Its Histological Subtypes: An International Multicenter Survey , 2011, Pancreas.
[30] Myung-Hwan Kim,et al. International Consensus Diagnostic Criteria for Autoimmune Pancreatitis: Guidelines of the International Association of Pancreatology , 2011, Pancreas.
[31] B. Petersen,et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[32] M. Deheragoda,et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[33] E. Seward,et al. The use of immunoglobulin g4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[34] B. Petersen,et al. Value of Serum IgG4 in the Diagnosis of Autoimmune Pancreatitis and in Distinguishing It From Pancreatic Cancer , 2007, The American Journal of Gastroenterology.
[35] B. Petersen,et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[36] T. Shimosegawa,et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal , 2006, Journal of Gastroenterology.
[37] K. Shiratori,et al. Chronic pancreatitis caused by an autoimmune abnormality , 1995, Digestive Diseases and Sciences.
[38] D. Sahani,et al. EUS findings in patients with autoimmune pancreatitis. , 2004, Gastrointestinal endoscopy.
[39] G. Zamboni,et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens , 2004, Virchows Archiv.
[40] H. Nakajima,et al. Morphological changes after steroid therapy in autoimmune pancreatitis , 2004, Scandinavian journal of gastroenterology.
[41] T. Smyrk,et al. Idiopathic Chronic Pancreatitis With Periductal Lymphoplasmacytic Infiltration: Clinicopathologic Features of 35 Cases , 2003, The American journal of surgical pathology.